Modulated electro-hyperthermia induced loco-regional and systemic tumor destruction in colorectal cancer allografts
/in Colorectal Cancer, Hyperthermia, International Publications /von 2018-01-01 / J Cancer 2018;9(1):41-53Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
/in Dendritic Cells, International Publications, NSCLC /von 2017-12-21 / BMC Cancer 2017 12;17(1):884Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
/in International Publications, Newcastle Disease Virus /von 2017-12-20 / Trends Immunol. 2018 03;39(3):209-221Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2017-12-12 / Clin. Cancer Res. 2018 Feb;24(4):766-776Advances in immunotherapeutic research for glioma therapy
/in Dendritic Cells, Glioblastoma, International Publications /von 2017-12-05 / J. Neurol. 2018 Apr;265(4):741-756Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
/in International Publications, Pancreatic Cancer /von 2017-12-01 / Ann. Oncol. 2017 Dec;28(12):2950-2961The clinical benefit of hyperthermia in pancreatic cancer: a systematic review
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2017-11-23 / Int J Hyperthermia 2018 11;34(7):969-979An update on the relevance of vaccine research for the treatment of metastatic melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-11-23 / Melanoma Manag 2017 Dec;4(4):203-215Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis
/in Glioblastoma, Hyperthermia, International Publications /von 2017-11-03 / BMJ Open 2017 Nov;7(11):e017387
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de